Hvsen Biotechnology Co., Ltd. logo

Hvsen Biotechnology Co., Ltd. (300871)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
23. 18
+0.04
+0.1729%
¥
3.97B Market Cap
- P/E Ratio
0.4% Div Yield
4.32M Volume
- Eps
¥ 23.14
Previous Close
Add Transaction
Day Range
22.98 23.47
Year Range
19.08 32.62
Want to track 300871 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300871 closed today higher at ¥23.18, an increase of 0.1729% from yesterday's close, completing a monthly increase of 6.1355% or ¥1.34. Over the past 12 months, 300871 stock gained 12.0348%.
300871 pays dividends to its shareholders, with the most recent payment made on Jul 06, 2026. The next estimated payment will be in In 10 months on Jul 06, 2027 for a total of ¥0.2.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.033%, based on the last three reports.
Hvsen Biotechnology Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 10, 2021.
The company's stock is traded on one exchange.

300871 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Hvsen Biotechnology Co., Ltd. (300871) FAQ

What is the stock price today?

The current price is ¥23.18.

On which exchange is it traded?

Hvsen Biotechnology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300871.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 3.97B.

Has Hvsen Biotechnology Co., Ltd. ever had a stock split?

Hvsen Biotechnology Co., Ltd. had 1 splits and the recent split was on May 10, 2021.

Hvsen Biotechnology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Jie Han CEO
XSHE Exchange
CNE1000047H6 ISIN
CN Country
1,028 Employees
6 Jul 2026 Last Dividend
10 May 2021 Last Split
- IPO Date

Overview

Hvsen Biotechnology Co., Ltd., established in 2002 and located in Wuhan, China, is a prominent player in the field of biotechnology. The company embarks on the research and development, as well as the manufacturing, of macrolides Active Pharmaceutical Ingredients (APIs) and preparations. Hvsen Biotechnology extends its services not only within China but also internationally, catering to a diverse range of needs in the pharmaceutical industry. The firm is well-regarded for its innovative approach towards creating veterinary drug products, including raw materials and preparations, alongside traditional Chinese medicine extractives.

Products and Services

Hvsen Biotechnology Co., Ltd. offers an expansive portfolio of products and services that cater to the veterinary pharmaceutical sector:

  • Tylvalosin Tartrate Powders and Raw Materials: These are used in the manufacturing of veterinary medicines, specifically aimed at treating respiratory diseases in animals.
  • Florfenicol, Cefquinome Sulfate, and Tildipirosin Injections: These injections are designed to combat a wide range of bacterial infections in various animal species.
  • Florfenicol Powder/WSP: Another form of florfenicol, this water-soluble powder is particularly prescribed for the treatment of respiratory and enteric infections in poultry and swine.
  • Tylosin Tartrate Soluble Powder: This antibiotic powder is used to treat and prevent diseases in livestock and poultry, caused by organisms sensitive to tylosin.
  • Tywasin Premix Products: Tywasin premix is used as a feed additive for livestock, aimed at maintaining health and enhancing growth by preventing bacterial infections.

The company's commitment to innovation allows it to produce a broad assortment of veterinary drug products from raw materials to finished preparations, including the development of traditional Chinese medicines' extractives for veterinary applications. Through its extensive product range and continuous research efforts, Hvsen Biotechnology Co., Ltd. demonstrates a strong commitment to improving animal health and welfare on a global scale.

Contact Information

Address: No.208 Zhangbai Road, Wuhan, China, 430042
Phone: 86 27 8860 5516